Dexamethasone, or MK-125, is a corticosteroid fluorinated at position 9 used to treat endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Developed in 1957, it is structurally similar to other corticosteroids like [hydrocortisone] and [prednisolone].[A188724] Dexamethasone was granted FDA approval on 30 October 1958.[L10695] In a press release for the Randomized Evaluation of COVID-19 Therapy (RECOVERY) trial on 16 June 2020, dexamethasone was recommended for use in COVID-19 patients with severe respiratory symptoms. Dexamethasone reduced deaths by approximately one third in patients requiring ventilation and by one fifth in those requiring oxygen.[L14318]
Neomycin and Polymyxin B Sulfates and Dexamethasone
Dexamethasone Intensol
Tobradex ST
Mardex 25 Kit
DEXAMETHASONE Sodium Phosphate
PHL-dexamethasone
Pro-dexamethasone - 4
Dexamethasone sodium phosphate
Tobradex
Apo-dexamethasone
Dexamethasone-omega
Hexadrol Phosphate Inj 10mg/ml
Accufix II Dec Model 033-212
Decadron Phosphate Eye Ear Sol 0.1%
Sandoz Tobramycin / Dexamethasone
TopiDex
Encor Dec Model 033-856 Imp 0.5mg/imp
Dexasone 0.75mg
Dexasone 0.5mg
Indication
Dexamethasone and [ciprofloxacin] otic suspension is indicated for bacterial infections with inflammation in acute otitis media and acute otitis externa.[L10698] Intramuscular and intravenous injections are indicated for a number of endocrine, rheumatic, collagen, dermatologic, allergic, ophthalmic, gastrointestinal, respiratory, hematologic, neoplastic, edematous, and other conditions.[L10701] Oral tablets are indicated for the treatment of multiple myeloma.[L10710] An intravitreal implant is indicated for some forms of macular edema and non-infectious posterior uveitis affecting the posterior of the eye.[L10719] Various ophthalmic formulations are indicated for inflammatory conditions of the eye.[L10704,L10707,L10713,L10716,L10722,L10725]
Categories
Adrenal Cortex Hormones
Adrenals
Agents Causing Muscle Toxicity
Agents for Treatment of Hemorrhoids and Anal Fissures for Topical Use
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
